logo
episode-header-image
Jul 2024
10m 45s

Fake it till you make it - the rise and ...

LiSTNR
About this episode

Dupes are the new copycat trend.

From cosmetics to accessories, electronics, homeware and even motor cars, for every high quality product with a big price tag on the market, there seems to be a cheap alternative ready to go. 

But how are these companies making dupes get away with it? And what can the owners of the original product do to protect their intellectual property?

Thomson Geer Lawyers Marlia Saunders, who specialises in intellectual property law joined Helen Smith on The Briefing to explain.

Follow The Briefing:
TikTok: @listnrnewsroom
Instagram: @listnrnewsroom @thebriefingpodcast 
YouTube: @LiSTNRnewsroom
Facebook: @LiSTNR Newsroom

See omnystudio.com/listener for privacy information.

Up next
Today
Tragedy for missing NT girl + Bondi Beach Royal Commission findings
Headlines: Body of missing Sharon found near Alice Springs The US gives a cost estimate for the Iran war Mark Latham to pay $100k for tweets More Aussie residents now from India than England ... and the top 50 Aussie films Deep Dive: The Royal Commission into Antisemitism and Soc ... Show More
17m 40s
Yesterday
Wong secures China fuel deal + The five-minute fix for trauma
Thursday Headlines: China to resume jet fuel exports to Australia Pauline Hanson billed taxpayers for multiple flights to fundraisers Family of missing Alice Springs girl say they’re ‘desperate’ for her return Australia’s meth use soars to record highs Australia’s best places to ... Show More
21m 20s
Yesterday
Mum of accused killer cop arrested + Inflation jump explained
Headlines: Child abuse material found at Dezi Freeman’s home Mum of Beau Lamarre-Condon charged with witness tampering James Comey, former FBI director, faces new retribution charges ... and a dinner menu fit for a king Deep Dive: Inflation is on the rise again, with consumer pri ... Show More
15m 46s
Recommended Episodes
Aug 2025
Buy discount Ozempic here now click this link
In the past couple years, demand has gone wild for drugs like Ozempic – and its cousins, Zepbound, Wegovy, and Mounjaro. For people who had never been able to lose weight before, suddenly the numbers on the scale were plummeting. And everybody wanted to get their hands on them. N ... Show More
32m 6s
Apr 2025
DNA and Bankruptcy Collide With 23andMe
The genetic testing company 23andMe filed for bankruptcy in March, after years of slowing sales, legal trouble, and a declining stock price. And now, the valuable trove of genetic data the company owns is for sale, sparking privacy concerns.  On today’s Big Take, Bloomberg biotec ... Show More
16m 30s
Dec 2024
Big bets on trendy glasses to be the future of augmented reality
Xreal, one of the leading players in the augmented reality glasses market, released its latest product - the Xreal One Series. For the first time, it designed its own chip for the glasses. At the same time, companies like Meta and Apple are pushing the boundaries of what is possi ... Show More
33m 37s
May 2016
Carl T. Bogus, Kenneth R. Harney
<img src="https://assets.podomatic.net/ts/ed/04/0c/ralphnaderradiohour/3000x3000_11413413.jpg" alt="itunes pic" /><br /><p>Ralph talks to anti-trust expert, professor Carl T. Bogus, about how corporate mergers are stifling innovation and screwing workers and real estate columnist ... Show More
57m 30s
Apr 2025
The Fraud Trial That Became JPMorgan's Headache
Charlie Javice sold her financial aid startup Frank to JPMorgan Chase for $175 million. But soon after the ink on the deal was dry, the bank discovered that their new acquisition was not at all what it seemed. WSJ’s Alexander Saeedy explains how a trial about fraud committed agai ... Show More
20m 47s